Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
27.99
-1.20 (-4.11%)
At close: Feb 13, 2026, 4:00 PM EST
28.54
+0.55 (1.96%)
After-hours: Feb 13, 2026, 7:47 PM EST
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.49 billion as of February 13, 2026. Its market cap has increased by 93.06% in one year.
Market Cap
1.49B
Enterprise Value
1.22B
1-Year Change
93.06%
Ranking
Category
Stock Price
$27.99
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.49B, an increase of 128.20%. That is a compound annual growth rate of 20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.49B | 6.47% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.66B |
| Oculis Holding AG | 1.66B |
| Enliven Therapeutics | 1.66B |
| Nurix Therapeutics | 1.63B |
| Veradermics | 1.62B |
| Definium Therapeutics | 1.60B |
| Oruka Therapeutics | 1.60B |
| Relay Therapeutics | 1.58B |